Table 2.
Infection types (WG-3) | 8. We recommend that challenge with LPS is not an appropriate model for replicating human sepsis | R |
9. We recommend that microorganisms used in animal models preferentially replicate those commonly found in human sepsis | ||
e. Consider modeling sepsis syndromes that are initiated at sites other than the peritoneal cavity (e.g., lung, urinary tract, brain) | C | |
Organ Failure/ Dysfunction (WG-4) | 10. Organ/system dysfunction is defined as life-threatening deviation from normal for that organ/system based on objective evidence | R |
11. Not all activities in an individual organ/system need to be abnormal for organ dysfunction to be present | ||
12. To define objective evidence of the severity of organ/system dysfunction, a scoring system should be developed, validated and used, or use an existing scoring system | ||
13. Not all experiments must measure all parameters of organ dysfunction but animal models should be fully exploited | ||
f. Avoid hypoglycemia | C |
R recommendation strength, C consideration strength